Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 382 results in range #21 to #402.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Proffered Protocols‏‎ (1 revision)
  2. Archived: 2010 COPD/Asthma Call Summaries‏‎ (1 revision)
  3. Archived: 2012 QIBA US SWS Technical Committee call summaries‏‎ (1 revision)
  4. Steering Committee Call Summaries Archive‏‎ (1 revision)
  5. Archived: 2016 Lung Density BC Call Summaries‏‎ (1 revision)
  6. Alzheimer's Disease PET Archive‏‎ (1 revision)
  7. FDG-PET Archive‏‎ (1 revision)
  8. Tips for Extracting Protocols into the UPICT Template‏‎ (1 revision)
  9. Call Agenda Topics‏‎ (1 revision)
  10. Archive - Initial Target Selection and Roadmap‏‎ (1 revision)
  11. Additional letters of support can be found here‏‎ (1 revision)
  12. Archived Versions of QIBA Vol CT - Group 3A draft documents‏‎ (1 revision)
  13. Orphan Documents‏‎ (1 revision)
  14. QIBA Conformance Statement Template‏‎ (1 revision)
  15. Submitted Protocols‏‎ (1 revision)
  16. Retirement Process‏‎ (1 revision)
  17. Working Documents Archive‏‎ (1 revision)
  18. Follow-up Editorial‏‎ (1 revision)
  19. Joe's test‏‎ (1 revision)
  20. Archived: 2009 COPD/Asthma Call Summaries‏‎ (1 revision)
  21. Consensus Protocols‏‎ (1 revision)
  22. Archived - 2011 fMRI Reproducibility Call Summaries‏‎ (1 revision)
  23. MR Draft Proffered Protocols‏‎ (1 revision)
  24. Project 2a: Assessing Measurement Variability of Lung Lsions in Patient Data Sets‏‎ (1 revision)
  25. Submission Process‏‎ (1 revision)
  26. Profile: CT Lung Nodule Response‏‎ (1 revision)
  27. CT Draft Proffered Protocols‏‎ (1 revision)
  28. Archived - 2010-2011 fMRI Reproducibility Call Summaries‏‎ (1 revision)
  29. Phantom Development‏‎ (1 revision)
  30. 2022-07-19 Process Committee Agenda‏‎ (1 revision)
  31. QIBA vCT Lung Cancer Template (Editable)‏‎ (1 revision)
  32. FDG-PET Reference Material‏‎ (1 revision)
  33. Archived: fMRI Reproducibility Call Summaries‏‎ (1 revision)
  34. Digital Reference Objects-Images‏‎ (1 revision)
  35. 2022-08-02 Process Committee Agenda‏‎ (1 revision)
  36. Lesion Sizing Toolkit‏‎ (1 revision)
  37. QIBA vCT Template‏‎ (1 revision)
  38. Quantitative Computation‏‎ (1 revision)
  39. 2022-08-16 Process Committee Agenda‏‎ (1 revision)
  40. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility‏‎ (1 revision)
  41. Julie's COPD archive‏‎ (1 revision)
  42. Archived: 2011 CT Volumetry - Group 3A Call Summaries‏‎ (1 revision)
  43. FDG-PET CT Template‏‎ (1 revision)
  44. Region of Interest (ROI) Definition‏‎ (1 revision)
  45. FMRI‏‎ (1 revision)
  46. CT Angiography Profile Draft Archive‏‎ (1 revision)
  47. Normalization Process‏‎ (1 revision)
  48. QIBA Posters from RSNA Annual Meetings Archive‏‎ (1 revision)
  49. MR Archive‏‎ (1 revision)
  50. QIBA COPD/Asthma Committee‏‎ (1 revision)
  51. CTA, Clinically Feasible Profile‏‎ (1 revision)
  52. Atherosclerosis Biomarkers Profile Draft Archive‏‎ (1 revision)
  53. VirtualScopics, Inc.- Software Development for Analysis of QIBA DCE-MRI Phantom Data‏‎ (1 revision)
  54. Draft Consensus Protocols‏‎ (1 revision)
  55. 2022-09-06 Process Committee Agenda‏‎ (1 revision)
  56. Scratch Page for CT Volumetry‏‎ (1 revision)
  57. Archive‏‎ (1 revision)
  58. List of Registered Conformant Users (Self-attestation‏‎ (1 revision)
  59. Archived: 2011 COPD/Asthma Call Summaries‏‎ (1 revision)
  60. Draft Proffered Protocols‏‎ (2 revisions)
  61. DWI Profile Draft Archive‏‎ (2 revisions)
  62. CEUS Task Force (TF) Call Summaries‏‎ (2 revisions)
  63. Archive - Lung Density‏‎ (2 revisions)
  64. QIBA Planning Committee‏‎ (2 revisions)
  65. Consensus Process‏‎ (2 revisions)
  66. QIBA FDG-PET/CT SUV Subcommittee Site‏‎ (2 revisions)
  67. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries‏‎ (2 revisions)
  68. Dept of Research Scatch Page‏‎ (2 revisions)
  69. Groundwork and Profiling‏‎ (2 revisions)
  70. User Page Template‏‎ (2 revisions)
  71. Dana-Farber Cancer Institute‏‎ (2 revisions)
  72. Fused Images‏‎ (2 revisions)
  73. Moc technical committee‏‎ (2 revisions)
  74. Modality Committee Archive‏‎ (2 revisions)
  75. Archived DCE-MRI Profiles‏‎ (2 revisions)
  76. 2015 Call Summaries‏‎ (2 revisions)
  77. Archived: fMRI Bias WG Call Summaries‏‎ (2 revisions)
  78. Example Use Case for Open Image Archives‏‎ (2 revisions)
  79. 2014 Call Summaries‏‎ (2 revisions)
  80. 2022-03-01 Process Committee Agenda‏‎ (2 revisions)
  81. Committee on Image Archives‏‎ (2 revisions)
  82. CTV-AD Considerations for Future Editions‏‎ (2 revisions)
  83. Perlman Advisory Group‏‎ (2 revisions)
  84. Process Education‏‎ (2 revisions)
  85. FMRI-DICOM WG Call Summaries‏‎ (2 revisions)
  86. 2022-05-03 Process Committee Agenda‏‎ (2 revisions)
  87. ASFNR Materials - Abstract for Review‏‎ (2 revisions)
  88. Clinical Trials Collaboration‏‎ (2 revisions)
  89. Archived: 2013 fMRI Bias WG Call Summaries‏‎ (2 revisions)
  90. 2022-03-15 Process Committee Agenda‏‎ (2 revisions)
  91. Agenda from 02.17.2012 FDG-PET Tech Committee Call‏‎ (2 revisions)
  92. 2022-06-21 Process Committee Agenda‏‎ (2 revisions)
  93. 2022-07-05 Process Committee Agenda‏‎ (2 revisions)
  94. DWI Profile Development Archive‏‎ (2 revisions)
  95. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes‏‎ (3 revisions)
  96. CoreLab Partners, Inc., Round-2‏‎ (3 revisions)
  97. Roster‏‎ (3 revisions)
  98. 2020‏‎ (3 revisions)
  99. Stakeholder Viewpoints‏‎ (3 revisions)
  100. Johns Hopkins University School of Medicine, Round-2‏‎ (3 revisions)
  101. Julie's test page‏‎ (3 revisions)
  102. QIBA fMRI Subcommittee Call Summaries‏‎ (3 revisions)
  103. MSK Biomarker Committee Call Summaries‏‎ (3 revisions)
  104. Lung Nodule Assessment in CT Screening Call Summary Archive‏‎ (3 revisions)
  105. What Are Profiles and Protocols?‏‎ (3 revisions)
  106. Initial Target Selection‏‎ (3 revisions)
  107. QIBA Informational Meeting (Dec 1st at RSNA 2008) - Slide Content Review‏‎ (3 revisions)
  108. 2022-02-15 Process Committee Agenda‏‎ (3 revisions)
  109. MR DWI of the ADC, Clinically Feasible Profile‏‎ (3 revisions)
  110. QIBA Wiki Improvements‏‎ (3 revisions)
  111. UPICT FDG-PET/CT Protocol Working Group‏‎ (3 revisions)
  112. Profile Strategy for Vol CT‏‎ (3 revisions)
  113. U Penn‏‎ (3 revisions)
  114. UPICT Alzheimer's Disease/ Dementia Imaging Protocol Writing Group‏‎ (3 revisions)
  115. QIBA and UPICT posters from RSNA 2011 Annual Meeting‏‎ (3 revisions)
  116. Archived "What is a Profile?" description as of 08.19.2011‏‎ (3 revisions)
  117. How to Create a Google Doc‏‎ (3 revisions)
  118. Ambition Levels for Collaboration‏‎ (3 revisions)
  119. How to use QIBA Profiles‏‎ (3 revisions)
  120. SPECT TC99m BC Call Summaries Archive‏‎ (3 revisions)
  121. How to Upload Documents to the UPICT Library‏‎ (3 revisions)
  122. QIBA posters from RSNA 2015 Annual Meeting‏‎ (4 revisions)
  123. Process Committee Agenda Archive‏‎ (4 revisions)
  124. University of Colorado Denver, Department of Radiology‏‎ (4 revisions)
  125. Phantom Development Technical Subcommittee‏‎ (4 revisions)
  126. 2022-05-17 Process Committee Agenda‏‎ (4 revisions)
  127. QIBA Leadership Slides‏‎ (4 revisions)
  128. Acquisition Protocols Technical Subcommittee‏‎ (4 revisions)
  129. QIBA Kiosk Content Review‏‎ (4 revisions)
  130. Voting Process‏‎ (4 revisions)
  131. VU University Medical Center, The Netherlands, Round-2‏‎ (4 revisions)
  132. Project 2a: Assessing Measurement Variability of Lung Lesions in Patient Data Sets‏‎ (4 revisions)
  133. VolCT - Group 3B‏‎ (4 revisions)
  134. Claim Language/Detail‏‎ (4 revisions)
  135. 2022-04-05 Process Committee Agenda‏‎ (4 revisions)
  136. Group 3A Call Summaries Archive‏‎ (4 revisions)
  137. Julie's test‏‎ (4 revisions)
  138. ASL Meeting Summaries Archive‏‎ (5 revisions)
  139. ARCHIVE‏‎ (5 revisions)
  140. SPECT BC Call Summaries Archive‏‎ (5 revisions)
  141. Atherosclerosis Biomarkers by CTA, Clinically Feasible Profile‏‎ (5 revisions)
  142. Moc-up page‏‎ (5 revisions)
  143. Documents / Call Summaries‏‎ (5 revisions)
  144. Johns Hopkins University School of Medicine‏‎ (5 revisions)
  145. QIBA Artificial Data Evaluation Software‏‎ (5 revisions)
  146. Tools and recommendation for structured literature review‏‎ (5 revisions)
  147. MR Acquisition Protocols‏‎ (5 revisions)
  148. University of Wisconsin‏‎ (5 revisions)
  149. Phantoms And Tests Subcommittee‏‎ (5 revisions)
  150. Ground Truth Strategy‏‎ (6 revisions)
  151. MRE Profile‏‎ (6 revisions)
  152. Myocardial Blood Flow Biomarker Committee‏‎ (6 revisions)
  153. Phantom Protocol & Data Analysis‏‎ (6 revisions)
  154. 2012 Call Summaries‏‎ (6 revisions)
  155. Bobby test‏‎ (6 revisions)
  156. Projects‏‎ (6 revisions)
  157. UPICT Library‏‎ (6 revisions)
  158. QIBA posters from RSNA 2019 Annual Meeting‏‎ (6 revisions)
  159. Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson‏‎ (6 revisions)
  160. CoreLab Partners, Inc.‏‎ (6 revisions)
  161. QIBA Leadership Reference Materials‏‎ (6 revisions)
  162. ISMRM/QIBA PDFF Biomarker Ctte‏‎ (6 revisions)
  163. Quality Control Metrics‏‎ (6 revisions)
  164. QIBA posters from RSNA 2016 Annual Meeting‏‎ (7 revisions)
  165. VirtualScopics, Inc.‏‎ (7 revisions)
  166. QIBA Ultrasound SWS Call Summary Archive‏‎ (7 revisions)
  167. Project 1a: Inter-scanner/ Inter-clinic Comparison of Reader Nodule Sizing in CT Imaging of a Phantom‏‎ (7 revisions)
  168. QIBA Profile Drafting Process‏‎ (7 revisions)
  169. Quantitative Response Metrics for Lung Cancer‏‎ (7 revisions)
  170. 2022-02-01 Process Committee Agenda‏‎ (7 revisions)
  171. David Geffen School of Medicine at UCLA, Department of Radiology‏‎ (7 revisions)
  172. SPECT Biomarker Ctte (proposed)‏‎ (7 revisions)
  173. Wiki Accounts‏‎ (7 revisions)
  174. Duke Brain Imaging and Analysis Center‏‎ (7 revisions)
  175. UPICT Template‏‎ (7 revisions)
  176. Industry‏‎ (7 revisions)
  177. QIBA posters from RSNA 2017 Annual Meeting‏‎ (7 revisions)
  178. Profile drafts‏‎ (7 revisions)
  179. Medical College of Wisconsin‏‎ (7 revisions)
  180. Duke University‏‎ (7 revisions)
  181. Invitation to Participate‏‎ (8 revisions)
  182. Columbia University Medical Center‏‎ (8 revisions)
  183. Reference Library‏‎ (8 revisions)
  184. Metrology Committee Call Summaries Archive‏‎ (8 revisions)
  185. Stakeholder Contacts‏‎ (8 revisions)
  186. How To's‏‎ (8 revisions)
  187. Document Archive‏‎ (8 revisions)
  188. QIBA posters from RSNA 2018 Annual Meeting‏‎ (8 revisions)
  189. Fmri PubMed search‏‎ (8 revisions)
  190. FMRI Working Documents Archive‏‎ (8 revisions)
  191. Clinical Sites‏‎ (8 revisions)
  192. Resources‏‎ (8 revisions)
  193. The University of Texas M.D. Anderson Cancer Center‏‎ (9 revisions)
  194. QIBA posters from RSNA 2013 Annual Meeting‏‎ (9 revisions)
  195. QIBA PDF-MRI Biomarker Committee Call Summaries Archive‏‎ (9 revisions)
  196. DTI MRI Biomarker Ctte‏‎ (9 revisions)
  197. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting‏‎ (9 revisions)
  198. University of Pennsylvania‏‎ (9 revisions)
  199. Catalog‏‎ (9 revisions)
  200. QIBA Concepts‏‎ (9 revisions)
  201. QIBA posters and plenary session presentation from RSNA 2011 Annual Meeting‏‎ (9 revisions)
  202. DCE-MRI Project Page‏‎ (9 revisions)
  203. Archive for Lung Nodule Assessment in CT Screening Draft Profiles‏‎ (9 revisions)
  204. Committee Template‏‎ (10 revisions)
  205. Combined Nuclear Medicine Biomarker Committee Call Summaries‏‎ (10 revisions)
  206. QIBA / QuIC-ConCePT Call Summaries‏‎ (10 revisions)
  207. FMRI moc profile‏‎ (10 revisions)
  208. VU University Medical Center, The Netherlands‏‎ (10 revisions)
  209. New Protocol Here‏‎ (10 revisions)
  210. QIBA Modality Committees‏‎ (11 revisions)
  211. Selection Process‏‎ (11 revisions)
  212. Claim Guidance‏‎ (11 revisions)
  213. QIBA posters from RSNA 2014 Annual Meeting‏‎ (11 revisions)
  214. QIBA Sustainability Implementation Committee (QSIC)‏‎ (11 revisions)
  215. Dr Tucker's New Test Page‏‎ (11 revisions)
  216. Profile Development‏‎ (11 revisions)
  217. University of Washington‏‎ (11 revisions)
  218. QIBA and UPICT posters from RSNA 2010 Annual Meeting‏‎ (11 revisions)
  219. What Are Profiles?‏‎ (12 revisions)
  220. QIBA for Technologists‏‎ (12 revisions)
  221. David Geffen School of Medicine at UCLA, Department of Radiology,Round-2‏‎ (12 revisions)
  222. Johns Hopkins Univ School of Medicine‏‎ (12 revisions)
  223. QIBA for Radiologists‏‎ (12 revisions)
  224. 2022-01-18 Process Committee Agenda‏‎ (12 revisions)
  225. US CEUS Call Summary Archive‏‎ (12 revisions)
  226. Change Tracking and File Naming‏‎ (13 revisions)
  227. CT Angiography Call Summaries Archive‏‎ (13 revisions)
  228. MRE BC Call Summaries Archive‏‎ (13 revisions)
  229. VolCT - Group 2‏‎ (13 revisions)
  230. FDG-PET Call Summaries Archive‏‎ (13 revisions)
  231. QIBA vCT Profile v1.1 edit site‏‎ (13 revisions)
  232. CEUS BC Call Summaries‏‎ (13 revisions)
  233. I-123 Biomarker Committee‏‎ (14 revisions)
  234. Executive Committee‏‎ (14 revisions)
  235. MRE Biomarker Committee Call Summaries‏‎ (14 revisions)
  236. Voting Privileges‏‎ (14 revisions)
  237. CT Acquisition Protocol Groundwork‏‎ (14 revisions)
  238. Vol-CT - 1B Group Call Summaries‏‎ (14 revisions)
  239. Maintenance Process‏‎ (15 revisions)
  240. QIBA for Statisticians‏‎ (15 revisions)
  241. UPICT TEST SITE - Modified‏‎ (15 revisions)
  242. EIBIR/QIBA ASL Biomarker Ctte‏‎ (15 revisions)
  243. Call Summaries Archive‏‎ (15 revisions)
  244. Publication Process‏‎ (15 revisions)
  245. PET Myocardial Blood Flow Call Summaries Archive‏‎ (16 revisions)
  246. Expressing Requirements‏‎ (16 revisions)
  247. CT Volumetry BC Call Summaries Archive‏‎ (16 revisions)
  248. Software Version Tracking‏‎ (16 revisions)
  249. Profile Conformance‏‎ (16 revisions)
  250. Vol-CT - 1A Group Call Summaries‏‎ (16 revisions)
  251. US SWS Call Summaries Archive‏‎ (16 revisions)
  252. PET Amyloid BC Call Summaries Archive‏‎ (16 revisions)
  253. DWI Literature Review‏‎ (17 revisions)
  254. Profile Editions‏‎ (17 revisions)
  255. Profile: FDG-PET Whole Body‏‎ (17 revisions)
  256. Trial Implementation Process-DRAFT PAGE‏‎ (17 revisions)
  257. Conformity Assessment‏‎ (18 revisions)
  258. QIBA for Regulators‏‎ (18 revisions)
  259. PDFF Biomarker Committee Call Summaries‏‎ (18 revisions)
  260. QIBA Profile Template‏‎ (18 revisions)
  261. QIBA and UPICT posters from RSNA 2009 Annual Meeting‏‎ (18 revisions)
  262. FMRI Project Page‏‎ (18 revisions)
  263. Duke University Medical Center‏‎ (19 revisions)
  264. MR Elastography of the Liver, Clinically Feasible Profile‏‎ (20 revisions)
  265. Covariates Rationale‏‎ (20 revisions)
  266. QIBA for Imaging Vendors‏‎ (21 revisions)
  267. Assessment Procedure Guidance‏‎ (22 revisions)
  268. ROI Definition‏‎ (22 revisions)
  269. Balloting Process‏‎ (22 revisions)
  270. AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte‏‎ (22 revisions)
  271. 2009 Profile Template Sketch‏‎ (23 revisions)
  272. Committee Organization‏‎ (23 revisions)
  273. Claim Confirmation Process‏‎ (24 revisions)
  274. PET Myocardial Blood Flow Call Summaries‏‎ (24 revisions)
  275. MR Coordinating Committee‏‎ (25 revisions)
  276. PET Tau Biomarker Committee‏‎ (25 revisions)
  277. TC99m Biomarker Committee‏‎ (25 revisions)
  278. List of Certified Conformant Users (QIBA Tested)‏‎ (26 revisions)
  279. NM Coordinating Committee‏‎ (26 revisions)
  280. QIBA Acknowledgments‏‎ (27 revisions)
  281. Quantitation Computation‏‎ (27 revisions)
  282. US Coordinating Committee‏‎ (29 revisions)
  283. VolCT - Colorado Group‏‎ (30 revisions)
  284. Guidance Document Process‏‎ (30 revisions)
  285. Small Lung Nodule BC Call Summaries Archive‏‎ (30 revisions)
  286. SPECT Call Summaries‏‎ (30 revisions)
  287. PDFF Biomarker Committee Call Summaries Archive‏‎ (31 revisions)
  288. Draft New Main Page‏‎ (32 revisions)
  289. 2013 Call Summaries‏‎ (32 revisions)
  290. QIBA f-MRI‏‎ (32 revisions)
  291. Lung Density BC Call Summaries‏‎ (34 revisions)
  292. Committee on Open Image Archives‏‎ (34 revisions)
  293. Segmentation and Markup Formats‏‎ (35 revisions)
  294. PET Myocardial Blood Flow Biomarker Committee‏‎ (35 revisions)
  295. QIBA posters from RSNA 2012 Annual Meeting‏‎ (35 revisions)
  296. Process Committee Call Summaries‏‎ (36 revisions)
  297. Synthetic DCE-MRI Data‏‎ (36 revisions)
  298. Example Use Case for Open Image archives‏‎ (37 revisions)
  299. Quantitative-MRI‏‎ (39 revisions)
  300. Committee Sunset Process‏‎ (39 revisions)
  301. Vol-CT 1C Group Call Summaries‏‎ (39 revisions)
  302. Phantom Development Subcommittee‏‎ (39 revisions)
  303. Communications Committee‏‎ (40 revisions)
  304. Clinical Applications and Biological Targets Subcommittee‏‎ (40 revisions)
  305. Combined: System Dependencies & Phantom Development Subcommittees‏‎ (40 revisions)
  306. AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte‏‎ (41 revisions)
  307. Lung Density/COPD BC Call Summaries Archive‏‎ (41 revisions)
  308. PDF BC Call Summaries Archive‏‎ (42 revisions)
  309. QIBA PET Amyloid Biomarker Committee Call Summaries‏‎ (44 revisions)
  310. QIBA Collaborations‏‎ (46 revisions)
  311. PDFF Biomarker Ctte‏‎ (48 revisions)
  312. QIBA/RIC ctte‏‎ (50 revisions)
  313. Steering Committee‏‎ (50 revisions)
  314. MRE Biomarker Ctte‏‎ (51 revisions)
  315. System Dependencies Subcommittee‏‎ (51 revisions)
  316. QIBA Profile Stages‏‎ (52 revisions)
  317. Archived Versions‏‎ (52 revisions)
  318. DWI MR BC Call Summaries Archive‏‎ (53 revisions)
  319. QIBA Overview‏‎ (54 revisions)
  320. How to Write a Profile‏‎ (54 revisions)
  321. UPICT‏‎ (55 revisions)
  322. Review Process‏‎ (56 revisions)
  323. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)‏‎ (56 revisions)
  324. Pulse-Echo Quantitative Ultrasound (PEQUS) Call Summaries‏‎ (57 revisions)
  325. CT Coordinating Committee‏‎ (57 revisions)
  326. Vetting Requirements‏‎ (57 revisions)
  327. DSC-MRI Call Summaries Archive‏‎ (58 revisions)
  328. Public Comment Process‏‎ (59 revisions)
  329. Revision for "What is a Profile?" as of 08.19.2011‏‎ (60 revisions)
  330. MSK Biomarker Committee Call Summaries Archive‏‎ (61 revisions)
  331. Technical Confirmation Process‏‎ (62 revisions)
  332. VolCT - Group 1B‏‎ (65 revisions)
  333. QIBA Newsletter Archive‏‎ (67 revisions)
  334. Standardized Uptake Value (SUV)‏‎ (68 revisions)
  335. PUBLIC COMMENT WORK PAGE‏‎ (69 revisions)
  336. Pilot Conformance Projects Under Development‏‎ (70 revisions)
  337. MSK Biomarker Ctte‏‎ (72 revisions)
  338. List of Registered Conformant Users (Self-attestation)‏‎ (72 revisions)
  339. Committee Procedures‏‎ (78 revisions)
  340. SPECT Biomarker Ctte‏‎ (80 revisions)
  341. QIBA Profile Conformance‏‎ (89 revisions)
  342. DWI MR Biomarker Ctte‏‎ (92 revisions)
  343. DSC MRI Biomarker Ctte‏‎ (94 revisions)
  344. QIBA DCE-MRI Technical Committee Call Summaries‏‎ (94 revisions)
  345. Ultrasound CEUS BC‏‎ (96 revisions)
  346. CT Angiography Biomarker Ctte‏‎ (99 revisions)
  347. Volume Blood Flow Call Summaries‏‎ (101 revisions)
  348. Comment Resolutions‏‎ (101 revisions)
  349. VolCT - Group 1A‏‎ (104 revisions)
  350. Metrology Committee‏‎ (104 revisions)
  351. QIBA News‏‎ (106 revisions)
  352. DCE-MRI BC Call Summaries Archive‏‎ (109 revisions)
  353. About QIBA‏‎ (114 revisions)
  354. PET Amyloid Biomarker Ctte‏‎ (119 revisions)
  355. QIBA Protocol/Profile Implementation Feedback Process‏‎ (120 revisions)
  356. Work Product for Review‏‎ (124 revisions)
  357. Process Committee Call Summaries Archive‏‎ (127 revisions)
  358. Test Page for Joe‏‎ (135 revisions)
  359. Test joe protocols‏‎ (136 revisions)
  360. Process‏‎ (140 revisions)
  361. QIBA PDF-MRI Technical Committee Call Summaries‏‎ (142 revisions)
  362. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites‏‎ (149 revisions)
  363. FMRI Call Summaries Archive‏‎ (149 revisions)
  364. VolCT - Group 1C‏‎ (150 revisions)
  365. DCE MRI Biomarker Ctte‏‎ (157 revisions)
  366. CT Small Lung Nodule Biomarker Ctte‏‎ (165 revisions)
  367. Monthly FDG-PET Call Summaries‏‎ (189 revisions)
  368. FMRI Call Summaries‏‎ (189 revisions)
  369. Education‏‎ (197 revisions)
  370. COPD Group Call Summaries‏‎ (221 revisions)
  371. Committees‏‎ (225 revisions)
  372. VolCT - Group 3A‏‎ (226 revisions)
  373. Lung Density Biomarker Ctte‏‎ (250 revisions)
  374. Perfusion, Diffusion and Flow-MRI Biomarker Ctte‏‎ (305 revisions)
  375. FDG-PET Biomarker Ctte‏‎ (307 revisions)
  376. Call Summaries‏‎ (336 revisions)
  377. Ultrasound SWS Biomarker Ctte‏‎ (385 revisions)
  378. Profiles‏‎ (436 revisions)
  379. Process Coordinating Committee‏‎ (444 revisions)
  380. FMRI Biomarker Ctte‏‎ (506 revisions)
  381. CT Volumetry Biomarker Ctte‏‎ (565 revisions)
  382. Main Page‏‎ (643 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)